Bausch & Lomb Corp (BLCO.TO)
21.06
-0.04
(-0.19%)
CAD |
TSX |
May 31, 16:00
Bausch & Lomb Enterprise Value: 13.28B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 13.28B |
| May 30, 2024 | 13.29B |
| May 29, 2024 | 13.26B |
| May 28, 2024 | 13.26B |
| May 27, 2024 | 12.97B |
| May 24, 2024 | 13.12B |
| May 23, 2024 | 13.00B |
| May 22, 2024 | 12.77B |
| May 21, 2024 | 12.88B |
| May 17, 2024 | 12.88B |
| May 16, 2024 | 13.17B |
| May 15, 2024 | 13.03B |
| May 14, 2024 | 13.01B |
| May 13, 2024 | 13.03B |
| May 10, 2024 | 13.29B |
| May 09, 2024 | 13.17B |
| May 08, 2024 | 13.04B |
| May 07, 2024 | 13.06B |
| May 06, 2024 | 12.82B |
| May 03, 2024 | 12.29B |
| May 02, 2024 | 12.54B |
| May 01, 2024 | 12.52B |
| April 30, 2024 | 12.88B |
| April 29, 2024 | 12.92B |
| April 26, 2024 | 12.96B |
| Date | Value |
|---|---|
| April 25, 2024 | 13.02B |
| April 24, 2024 | 13.09B |
| April 23, 2024 | 13.01B |
| April 22, 2024 | 12.94B |
| April 19, 2024 | 12.95B |
| April 18, 2024 | 12.78B |
| April 17, 2024 | 12.85B |
| April 16, 2024 | 12.75B |
| April 15, 2024 | 12.92B |
| April 12, 2024 | 12.81B |
| April 11, 2024 | 13.10B |
| April 10, 2024 | 13.40B |
| April 09, 2024 | 13.60B |
| April 08, 2024 | 13.93B |
| April 05, 2024 | 13.73B |
| April 04, 2024 | 13.62B |
| April 03, 2024 | 13.69B |
| April 02, 2024 | 13.76B |
| April 01, 2024 | 14.04B |
| March 31, 2024 | 14.10B |
| March 28, 2024 | 13.92B |
| March 27, 2024 | 13.90B |
| March 26, 2024 | 13.81B |
| March 25, 2024 | 13.66B |
| March 22, 2024 | 13.46B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.731B
Minimum
Jun 13 2022
14.10B
Maximum
Mar 31 2024
11.58B
Average
11.54B
Median
May 03 2023
Enterprise Value Benchmarks
| Bausch Health Companies Inc | 33.45B |
| Biocure Technology Inc | 1.450M |
| Core One Labs Inc | 8.573M |
| Nova Mentis Life Science Corp | 2.919M |
| Nanosphere Health Sciences Inc | 0.2959M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -225.12M |
| Revenue (Quarterly) | 1.482B |
| Total Expenses (Quarterly) | 1.461B |
| EPS Diluted (Quarterly) | -0.6471 |
| Gross Profit Margin (Quarterly) | 61.42% |
| Profit Margin (Quarterly) | -15.20% |
| Earnings Yield | -6.15% |
| Operating Earnings Yield | 3.87% |
| Normalized Earnings Yield | -4.920 |